Oncology Stakeholders Offer Niche Recommendations To US FDA, But Who Will Ultimately Get Their Way?

Advocates, industry give wish lists for changes to Office of Oncology Excellence, but Commissioner Scott Gottlieb will ultimately determine who gets what.